Cerebral blood flow does not change following sodium nitroprusside infusion during hypothermic cardiopulmonary bypass

A. T. Roger, Donald Prough, D. A. Stump, G. P. Gravlee, K. C. Angert, R. C. Roy, S. A. Mills, L. Hinshelwood

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Changes in cerebral blood flow (CBF) associated with decreases in mean arterial pressure (MAP) produced by sodium nitroprusside (SNP) infusion were measured by intra-aortic injection of 133Xe in 17 patients during hypothermic cardiopulmonary bypass (CPB). In each patient, CBF was determined as baseline and then again following SNP-induced reduction of MAP. Two groups were studied. In Group I (n = 9), PaCO2 was maintained near 42 mm Hg uncorrected for nasopharyngeal temperature (NPT). In Group II (n = 8), PaCO2 was maintained near 60 mm Hg, uncorrected for NPT. Nasopharyngeal temperature, MAP, pump oxygenator flow, PaO2, and hematocrit were maintained within a narrow range in each patient during both studies. Since the baseline CBF determinations were conducted at the higher MAP in all subjects, we corrected post-SNP CBF data for the spontaneous decline that occurs over time during CPB. In Group I, a reduction in MAP from 76 ± 9 mm Hg (mean ± SD) to 50 ± 6 mm Hg was associated with a reduction in CBF from 17 ± 5 to 13 ± 3 ml·100 g·min-1 (P < 0.01), a decrease that became statistically insignificant once the time correction factor had been applied (16 ± 4 ml·100 g-1·min-1). In Group II, MAP declined from 75 ± 5 mm Hg to 54 ± 5 mm Hg, and CBF declined from 25 ± 10 to 17 ± 7 ml·100 g·min-1 (P < 0.01), but, again, after time correction, the CBF decline was statistically insignificant (22 ± 8 ml·100 g-1·min-1). We conclude that SNP infusion is associated with a decrease in CBF during hypothermic nonpulsatile CPB but that the decrease is not significant when corrected for the duration of cardiopulmonary bypass.

Original languageEnglish (US)
Pages (from-to)122-126
Number of pages5
JournalAnesthesia and Analgesia
Volume68
Issue number2
StatePublished - 1989
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Nitroprusside
Cardiopulmonary Bypass
Arterial Pressure
Temperature
Oxygenators
Hematocrit

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Roger, A. T., Prough, D., Stump, D. A., Gravlee, G. P., Angert, K. C., Roy, R. C., ... Hinshelwood, L. (1989). Cerebral blood flow does not change following sodium nitroprusside infusion during hypothermic cardiopulmonary bypass. Anesthesia and Analgesia, 68(2), 122-126.

Cerebral blood flow does not change following sodium nitroprusside infusion during hypothermic cardiopulmonary bypass. / Roger, A. T.; Prough, Donald; Stump, D. A.; Gravlee, G. P.; Angert, K. C.; Roy, R. C.; Mills, S. A.; Hinshelwood, L.

In: Anesthesia and Analgesia, Vol. 68, No. 2, 1989, p. 122-126.

Research output: Contribution to journalArticle

Roger, AT, Prough, D, Stump, DA, Gravlee, GP, Angert, KC, Roy, RC, Mills, SA & Hinshelwood, L 1989, 'Cerebral blood flow does not change following sodium nitroprusside infusion during hypothermic cardiopulmonary bypass', Anesthesia and Analgesia, vol. 68, no. 2, pp. 122-126.
Roger, A. T. ; Prough, Donald ; Stump, D. A. ; Gravlee, G. P. ; Angert, K. C. ; Roy, R. C. ; Mills, S. A. ; Hinshelwood, L. / Cerebral blood flow does not change following sodium nitroprusside infusion during hypothermic cardiopulmonary bypass. In: Anesthesia and Analgesia. 1989 ; Vol. 68, No. 2. pp. 122-126.
@article{a3ea3c93f9a64a4d99d8d141ff23a434,
title = "Cerebral blood flow does not change following sodium nitroprusside infusion during hypothermic cardiopulmonary bypass",
abstract = "Changes in cerebral blood flow (CBF) associated with decreases in mean arterial pressure (MAP) produced by sodium nitroprusside (SNP) infusion were measured by intra-aortic injection of 133Xe in 17 patients during hypothermic cardiopulmonary bypass (CPB). In each patient, CBF was determined as baseline and then again following SNP-induced reduction of MAP. Two groups were studied. In Group I (n = 9), PaCO2 was maintained near 42 mm Hg uncorrected for nasopharyngeal temperature (NPT). In Group II (n = 8), PaCO2 was maintained near 60 mm Hg, uncorrected for NPT. Nasopharyngeal temperature, MAP, pump oxygenator flow, PaO2, and hematocrit were maintained within a narrow range in each patient during both studies. Since the baseline CBF determinations were conducted at the higher MAP in all subjects, we corrected post-SNP CBF data for the spontaneous decline that occurs over time during CPB. In Group I, a reduction in MAP from 76 ± 9 mm Hg (mean ± SD) to 50 ± 6 mm Hg was associated with a reduction in CBF from 17 ± 5 to 13 ± 3 ml·100 g·min-1 (P < 0.01), a decrease that became statistically insignificant once the time correction factor had been applied (16 ± 4 ml·100 g-1·min-1). In Group II, MAP declined from 75 ± 5 mm Hg to 54 ± 5 mm Hg, and CBF declined from 25 ± 10 to 17 ± 7 ml·100 g·min-1 (P < 0.01), but, again, after time correction, the CBF decline was statistically insignificant (22 ± 8 ml·100 g-1·min-1). We conclude that SNP infusion is associated with a decrease in CBF during hypothermic nonpulsatile CPB but that the decrease is not significant when corrected for the duration of cardiopulmonary bypass.",
author = "Roger, {A. T.} and Donald Prough and Stump, {D. A.} and Gravlee, {G. P.} and Angert, {K. C.} and Roy, {R. C.} and Mills, {S. A.} and L. Hinshelwood",
year = "1989",
language = "English (US)",
volume = "68",
pages = "122--126",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Cerebral blood flow does not change following sodium nitroprusside infusion during hypothermic cardiopulmonary bypass

AU - Roger, A. T.

AU - Prough, Donald

AU - Stump, D. A.

AU - Gravlee, G. P.

AU - Angert, K. C.

AU - Roy, R. C.

AU - Mills, S. A.

AU - Hinshelwood, L.

PY - 1989

Y1 - 1989

N2 - Changes in cerebral blood flow (CBF) associated with decreases in mean arterial pressure (MAP) produced by sodium nitroprusside (SNP) infusion were measured by intra-aortic injection of 133Xe in 17 patients during hypothermic cardiopulmonary bypass (CPB). In each patient, CBF was determined as baseline and then again following SNP-induced reduction of MAP. Two groups were studied. In Group I (n = 9), PaCO2 was maintained near 42 mm Hg uncorrected for nasopharyngeal temperature (NPT). In Group II (n = 8), PaCO2 was maintained near 60 mm Hg, uncorrected for NPT. Nasopharyngeal temperature, MAP, pump oxygenator flow, PaO2, and hematocrit were maintained within a narrow range in each patient during both studies. Since the baseline CBF determinations were conducted at the higher MAP in all subjects, we corrected post-SNP CBF data for the spontaneous decline that occurs over time during CPB. In Group I, a reduction in MAP from 76 ± 9 mm Hg (mean ± SD) to 50 ± 6 mm Hg was associated with a reduction in CBF from 17 ± 5 to 13 ± 3 ml·100 g·min-1 (P < 0.01), a decrease that became statistically insignificant once the time correction factor had been applied (16 ± 4 ml·100 g-1·min-1). In Group II, MAP declined from 75 ± 5 mm Hg to 54 ± 5 mm Hg, and CBF declined from 25 ± 10 to 17 ± 7 ml·100 g·min-1 (P < 0.01), but, again, after time correction, the CBF decline was statistically insignificant (22 ± 8 ml·100 g-1·min-1). We conclude that SNP infusion is associated with a decrease in CBF during hypothermic nonpulsatile CPB but that the decrease is not significant when corrected for the duration of cardiopulmonary bypass.

AB - Changes in cerebral blood flow (CBF) associated with decreases in mean arterial pressure (MAP) produced by sodium nitroprusside (SNP) infusion were measured by intra-aortic injection of 133Xe in 17 patients during hypothermic cardiopulmonary bypass (CPB). In each patient, CBF was determined as baseline and then again following SNP-induced reduction of MAP. Two groups were studied. In Group I (n = 9), PaCO2 was maintained near 42 mm Hg uncorrected for nasopharyngeal temperature (NPT). In Group II (n = 8), PaCO2 was maintained near 60 mm Hg, uncorrected for NPT. Nasopharyngeal temperature, MAP, pump oxygenator flow, PaO2, and hematocrit were maintained within a narrow range in each patient during both studies. Since the baseline CBF determinations were conducted at the higher MAP in all subjects, we corrected post-SNP CBF data for the spontaneous decline that occurs over time during CPB. In Group I, a reduction in MAP from 76 ± 9 mm Hg (mean ± SD) to 50 ± 6 mm Hg was associated with a reduction in CBF from 17 ± 5 to 13 ± 3 ml·100 g·min-1 (P < 0.01), a decrease that became statistically insignificant once the time correction factor had been applied (16 ± 4 ml·100 g-1·min-1). In Group II, MAP declined from 75 ± 5 mm Hg to 54 ± 5 mm Hg, and CBF declined from 25 ± 10 to 17 ± 7 ml·100 g·min-1 (P < 0.01), but, again, after time correction, the CBF decline was statistically insignificant (22 ± 8 ml·100 g-1·min-1). We conclude that SNP infusion is associated with a decrease in CBF during hypothermic nonpulsatile CPB but that the decrease is not significant when corrected for the duration of cardiopulmonary bypass.

UR - http://www.scopus.com/inward/record.url?scp=0024499980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024499980&partnerID=8YFLogxK

M3 - Article

C2 - 2492406

AN - SCOPUS:0024499980

VL - 68

SP - 122

EP - 126

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -